Collegium Pharmaceutical Inc (COLL) — Working Capital to Net Assets Ratio
Collegium Pharmaceutical Inc (COLL) has a Working Capital to Net Assets ratio of 58.6% as of September 2025. Working capital of $160.94 Million (current assets of $613.87 Million minus current liabilities of $452.93 Million) is measured against net assets of $274.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Collegium Pharmaceutical Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Collegium Pharmaceutical Inc Working Capital to Net Assets (2013–2024)
This chart shows how Collegium Pharmaceutical Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 58.6%, reflecting working capital of $160.94 Million against net assets of $274.81 Million USD. For the complete balance sheet picture, see COLL current and non-current assets.
Annual Working Capital to Net Assets for Collegium Pharmaceutical Inc (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Collegium Pharmaceutical Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Collegium Pharmaceutical Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -11.9% | $-27.25 Million | $228.84 Million | $482.26 Million | $509.51 Million | ▼ -52.7 pp |
| 2023 | 40.8% | $79.69 Million | $195.43 Million | $537.60 Million | $457.92 Million | ▲ +47.8 pp |
| 2022 | -7.1% | $-13.74 Million | $194.84 Million | $419.99 Million | $433.73 Million | ▼ -24.8 pp |
| 2021 | 17.7% | $35.98 Million | $202.93 Million | $315.54 Million | $279.57 Million | ▼ -2.9 pp |
| 2020 | 20.7% | $38.44 Million | $186.03 Million | $277.89 Million | $239.45 Million | ▼ -41.0 pp |
| 2019 | 61.7% | $53.95 Million | $87.43 Million | $255.72 Million | $201.76 Million | ▲ +7.1 pp |
| 2018 | 54.6% | $50.03 Million | $91.58 Million | $237.51 Million | $187.48 Million | ▼ -43.4 pp |
| 2017 | 98.0% | $102.00 Million | $104.08 Million | $133.48 Million | $31.49 Million | ▼ -2.5 pp |
| 2016 | 100.5% | $135.65 Million | $134.91 Million | $158.57 Million | $22.93 Million | ▼ -6.6 pp |
| 2015 | 107.1% | $91.12 Million | $85.07 Million | $96.88 Million | $5.76 Million | ▲ +58.7 pp |
| 2014 | 48.4% | $-5.92 Million | $-12.24 Million | $4.50 Million | $10.42 Million | ▼ -52.7 pp |
| 2013 | 101.1% | $5.64 Million | $5.58 Million | $8.26 Million | $2.62 Million | — |